(Q79602286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

9

David B Weiner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Jian Yan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Hanna Yoon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sanjeev Kumar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Mathura P Ramanathan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Natasha Corbitt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Michele Kutzler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Anlan Dai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Jean D Boyer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

411-421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Immunogen sequence: the fourth tier of AIDS vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Consensus and Ancestral State HIV Vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Effect of natural HIV-1 envelope V1-V2 sequence diversity on the binding of V3-specific and non-V3-specific antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Diversity considerations in HIV-1 vaccine selection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Transmission and pathogenesis of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300036

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17235321%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference